Topic: Cardiology

Fitbit and health screening and monitoring app FibriCheck, has announced a partnership enabling users in Belgium, […]

Cardiovascular disease (CVD) causes 3.9 million deaths in Europe every year. It is one of society’s […]

– New late-breaking data at TCT 2019 demonstrate that Abbott’s MitraClip™ is cost-effective for heart […]

Dive Brief: Boston Scientific and Medtronic shared clinical trial data on their stents in patients […]

Both and Zoll Medical, an Asahi Kasei (TYO:3407) subsidiary, and Becton Dickinson (NYSE:BDX) picked up contracts from the U.S. Defense Dept. […]

Abiomed certainly brought its A-game to the 31st annual Transcatheter Cardiovascular Therapeutics (TCT) conference– being […]

OrbusNeich Medical today said it won market approval in Japan for its Combo Plus coronary stent. […]

An increase in the number of surgical procedures taking place at ambulatory care centers could […]

Heart disease is a silent and often costly killer. About 610,000 people die of it […]

Robocath said today that it completed its first two coronary angioplasties performed with its R-One robotic […]

Abiomed (NSDQ:ABMD) said today that it won pre-market approval from the FDA for the latest version […]

Baylis Medical said today that it successfully completed the first Abbott (NYSE:ABT) MitraClip procedure with Baylis’ VersaCross transseptal […]

Abiomed (NSDQ:ABMD) today claimed a win in a German patent infringement case brought by Abbott (NYSE:ABT) subsidiary Thoratec. The […]

To demonstrate that treatment with the Revivent TC™ System is more effective than Guideline Directed […]

TORONTO, Sept. 23, 2019 /PRNewswire/ – Baylis Medical announced today the successful first MitraClip™ procedure performed using […]

According to a new study, a new approach to self-expanding transcatheter aortic valve replacement could […]

Boston Scientific has announced the key data that will be presented at the Transcatheter Cardiovascular Therapeutics […]

Saranas, a Houston, Texas firm, is releasing its novel Early Bird bleeding monitoring system in […]

Abbott (NYSE:ABT) said today that it won CE Mark approval for its Masters HP mechanical heart […]

Orchestra BioMed said today that it received breakthrough device designation from the FDA for its Virtue […]

UPDATE: Sept. 12, 2019: V-Wave said Thursday it’s received a second breakthrough device designation for its in-development implantable interatrial shunt, […]

Corvia Medical said it launched a heart failure device trial that will include the collection and […]

BioSig Technologies (NSDQ:BSGM) said yesterday that it signed a new licensing agreement with Mayo Clinic to […]

Non-invasive monitoring technology assists in managing heart failure patients TENAFLY,  N.J., Sept. 14, 2019 /PRNewswire/ — Sensible Medical […]

2019 has been an exciting year for Acutus Medical, a company that Needham & Co. […]

Dive Brief: Abbott said Tuesday it has developed an algorithm using artificial intelligence that could […]

CorWave today touted 60-day study results from its preclinical study to evaluate its left ventricular […]

Medtronic has been fielding complaints from physicians who have had trouble releasing the company’s Micra […]

iRhythm Technologies (NSDQ:IRTC) said yesterday that it closed its underwritten public offering of common stock for […]

Cook Medical today touted five-year data from a study into the use of its Zilver PTX […]

EBR Systems said today that it has received breakthrough device designation from the FDA for its […]

Alphabet’s Verily Life Sciences and iRhythm Technologies are bringing together data analytics and artificial intelligence […]

Dive Brief: Medtronic announced over the weekend favorable initial trial results for its investigational drug-coated […]